Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study

Autor: Sadettin Uslu, Semih Gulle, Gercek Sen, Ayse Cefle, Sema Yilmaz, Sinem Burcu Kocaer, Tuba Yuce Inel, Suleyman Serdar Koca, Servet Yolbas, Mehmet Akif Ozturk, Soner Senel, Nevsun Inanc, Huseyin Ediz Dalkilic, Ozgul Soysal Gunduz, Abdurrahman Tufan, Servet Akar, Ahmet Merih Birlik, Ismail Sari, Nurullah Akkoc, Fatos Onen

Publikováno v: Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)

Abstract Clinical data on the use of tumour necrosis factor inhibitors (TNFi) in late-onset ankylosing spondylitis (LoAS) are limited. The present study aimed to evaluate efficacy, safety, and treatment adherence associated with the initial use of TN

Externí odkaz: https://doaj.org/article/07ea3304416b46ad8c900013a1ca1f33

The inhibition of Src kinase suppresses the production of matrix metalloproteinases in from synovial fibroblasts and inhibits MAPK and STATs pathways

Autor: Osman Ciftci, Demet Yalçın Kehribar, Metin Ozgen, Servet Yolbas, Süleyman Serdar Koca, Neşe Başak Türkmen, Ahmet Yildirim, Ibrahim Hanifi Ozercan, Ebru Onalan Etem

Publikováno v: Turkish Journal of Medical Sciences

WOS:000691664800007 SCI PubMed ID33714238 Q3 Background/aim: The purpose of this study was to investigate the antiarthritic potentials of the inhibition of Src kinase in vivo and in vitro settings. Materials and methods: Arthritis was induced by intr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8064bdce9a61ff8aff5233e8e2b576b
https://doi.org/10.3906/sag-2008-274

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Autor: Johan Askling, Burkhard Möller, Matija Tomšič, Lennart T H Jacobsson, Jakub Zavada, Thorvardur Jon Love, Daniela Di Giuseppe, Adrian Ciurea, Manuel Pombo-Suarez, Maria José Santos, Bjorn Gudbjornsson, Pedro Avila-Ribeiro, Catalin Codreanu, Brigitte Michelsen, Michael John Nissen, Carlos Sánchez-Piedra, Lykke Midtbøll Ørnbjerg, Karen Minde Fagerli, Bente Glintborg, Žiga Rotar, Bénédicte Delcoigne, Gareth T. Jones, Ruxandra Ionescu, Servet Yolbas, Ulf Lindström, Lucie Nekvindová, Heikki Relas, Mikkel Østergaard, Nuh Atas, Florenzo Iannone, Kari K. Eklund

Publikováno v: Annals of the Rheumatic Diseases
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Lindström, U, Di Giuseppe, D, Delcoigne, B, Glintborg, B, Möller, B, Ciurea, A, Pombo-Suarez, M, Sanchez-Piedra, C, Eklund, K, Relas, H, Gudbjornsson, B, Love, T J, Jones, G T, Codreanu, C, Ionescu, R, Nekvindova, L, Závada, J, Atas, N, Yolbas, S, Fagerli, K M, Michelsen, B, Rotar, Tomšič, M, Iannone, F, Santos, M J, Avila-Ribeiro, P, Ørnbjerg, L M, Østergaard, M, Jacobsson, L T H, Askling, J & Nissen, M J 2021, ' Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration ', Annals of the Rheumatic Diseases, vol. 80, no. 11, 220097, pp. 1410-1418 . https://doi.org/10.1136/annrheumdis-2021-220097

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022e520d9e5e31bc0cc0baf6321a0476
http://europepmc.org/articles/PMC8522446

Subcutaneous and intravenous applications of abatacept therapy used in the treatment of rheumatoid arthritis show similar efficacy

Autor: Süleyman Serdar Koca, Burak Öz, Ahmet Yildirim, Ahmet Karataş, Servet Yolbas

Publikováno v: Ulusal Romatoloji Dergisi. 12:17-21

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b1d5b3d45e8766e6995afe00e4d4f6c9
https://doi.org/10.4274/raed.galenos.2020.07078

FRI0416 THE EFFICACY AND SAFETY OF ANTI-TNF A TREATMENT IN ANKYLOSING SPONDYLITIS PATIENTS WITH LATE ONSET COMPARED TO THOSE WITH ADULT ONSET; THE DATA FROM TURKBIO REGISTRY

Autor: Servet Akar, Ediz Dalkilic, Abdurrahman Tufan, Merih Birlik, Tuba Yuce Inel, Sinem Burcu Kocaer, Sadettin Uslu, Gerçek Can, Sema Yilmaz, S. Gulle, Ayse Cefle, Süleyman Serdar Koca, Ismail Sari, Nevsun Inanc, Fatos Onen, Soner Senel, Nurullah Akkoc, Servet Yolbas, Ozgul Soysal, Mehmet Akif Ozturk

Publikováno v: Spondyloarthritis – treatment.

Background The first symptoms of ankylosing spondylitis (AS) patients usually begin prior to 45 years, but can occur later in life. Objectives The purpose of this study is to evaluate the efficacy and safety of anti-TNFα treatment in late-onset AS (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d57998bf44051307334fa309165cabba
https://doi.org/10.1136/annrheumdis-2019-eular.5405